Page last updated: 2024-12-11
18-dehydroxycytochalasin h
Description
18-Dehydroxycytochalasin H is a **modified form of the natural product cytochalasin H**. Cytochalasins are a family of fungal metabolites known to **inhibit actin polymerization**, a crucial process in cell motility, structure, and signaling.
Here's a breakdown of its significance in research:
**1. Structure-Activity Relationship Studies:**
* The modification of cytochalasin H to create 18-dehydroxycytochalasin H allows researchers to investigate the role of the hydroxyl group at the 18th position in its biological activity.
* Understanding how modifications in the structure affect the compound's interaction with actin can lead to **development of more potent and selective inhibitors of actin polymerization**.
**2. Potential Therapeutic Applications:**
* Cytochalasins have shown promise in various therapeutic areas, including:
* **Anti-cancer therapy:** Inhibiting actin polymerization can disrupt tumor cell invasion and metastasis.
* **Anti-inflammatory therapy:** Reducing inflammation by interfering with immune cell migration.
* **Treatment of parasitic infections:** Disrupting the actin-based cytoskeleton of parasites.
* 18-Dehydroxycytochalasin H and similar modified cytochalasins might offer improved pharmacological properties over the natural product, making them **more suitable for therapeutic applications**.
**3. Research Tools:**
* Cytochalasins, including 18-dehydroxycytochalasin H, are valuable tools for **studying cellular processes involving actin**.
* Researchers can use these compounds to **block actin polymerization in vitro and in vivo** and observe the resulting cellular effects, providing insights into actin's functions in cell division, migration, and other essential processes.
**4. Chemical Biology and Drug Discovery:**
* Understanding the mechanism of action of 18-dehydroxycytochalasin H and its analogs can lead to the design of **novel drugs that target actin polymerization** and address various unmet medical needs.
* This compound serves as a starting point for **chemical library screening** to identify new leads for drug development.
**Overall, 18-dehydroxycytochalasin H is an important research tool due to its potential applications in studying actin polymerization, developing new therapies, and exploring chemical biology and drug discovery avenues.**
18-dehydroxycytochalasin H: structure given in first source; an inhibitor of HIV-1 protease; isolated from a bark-inhabiting Ascomycete, Hypoxylon fragiforme [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 21584098 |
MeSH ID | M0203509 |
Synonyms (1)
Synonym |
18-dehydroxycytochalasin h |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |